Memory enhancement in rats by soybean and tempeh extracts is associated with improved cholinergic and reduced neuroinflammatory activities by Alia Hamad, et al.
Sains Malaysiana 45(9)(2016): 1299–1310  
Memory Enhancement in Rats by Soybean and Tempeh Extracts is Associated with 
Improved Cholinergic and Reduced Neuroinflammatory Activities
(Peningkatan Daya Ingatan dalam Tikus oleh Ekstrak Soya dan Tempeh dikaitkan dengan 
Peningkatan Aktiviti Kolinergik dan Pengurangan Aktiviti Keradangan)
ALIA HAMAD, VASUDEVAN MANI*, KALAVATHY RAMASAMY, SIONG MENG LIM, 
ABU BAKAR ABDUL MAJEED
ABSTRACT
The continued progression of neurodegeneration may result in dementia. The present study compared the neuroprotective 
activities between soybean and tempeh extracts in rats. The extracts were administered orally at 10, 20 and 40 mg/kg for 
15 days. Radial arm maze and elevated plus maze served as exteroceptive behavioural models for memory measuring. 
Brain cholinergic activities (acetylcholine and acetylcholinesterase) and neuroinflammatory related cytokines interleukin 
1β and interleukin-10 were also tested. Soybean and tempeh extracts significantly improved memory, but overall 40 mg/
kg tempeh showed better improvement (p<0.05). The tempeh extracts at 20 and 40 mg/kg exhibited a significant (p<0.05) 
increase and decrease in the level of acetylcholine and acetylcholinesterase activities, respectively. Tempeh extract (40 
mg/kg) resulted in greater reduction (p<0.05) of inflammation than soybean extract. Altogether, tempeh extract may be 
beneficial in the management and prevention of dementia and Alzheimer’s disease.
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ABSTRAK
Neurodegradasi yang berlanjutan boleh menyebabkan penyakit demensia. Kajian ini membandingkan keupayaan ekstrak 
soya dan tempeh untuk melindungi otak menggunakan tikus. Ekstrak tersebut telah diberi secara oral pada 10, 20 dan 
40 mg/kg selama 15 hari. Pengukuran daya ingatan dijalankan dengan menggunakan pagar sesat bentuk jejari dan 
pagar sesat bersilang tinggi yang merupakan model rangsangan persekitaran. Aktiviti kolinergik otak (asetilkolina dan 
asetilkolinesterase) dan sitokin yang berkaitan dengan keradangan otak IL-1β dan IL10 turut diuji. Ekstrak soya dan 
tempeh mampu meningkatkan daya ingatan, namun 40 mg/kg ekstrak tempeh menunjukkan peningkatan daya ingatan 
yang paling ketara (p<0.05). Ekstrak tempeh (20 dan 40 mg/kg) menunjukkan peningkatan dan penurunan yang berkesan 
(p<0.05) dalam aktiviti asetilkolina (p<0.05) dan asetilkolinesterase. Ekstrak tempeh 40 mg/kg mengurangkan keradangan 
(p<0.05) yang lebih ketara berbanding dengan ekstrak soya. Sebagai kesimpulan, ekstrak tempeh mungkin berkesan 
mencegah demensia dan juga penyakit Alzheimer. 
Kata kunci: Daya ingatan; kolinergik; radang otak; soya; tempeh
INTRODUCTION
Neurodegeneration is a series of neuronal dysfunction due 
to the continual death of neurons. The loss of brain neurons 
leads to major age-related disease like dementia. The most 
deteriorating effect of neurodegeneration is memory loss. 
The primary mechanism involved in memory loss is the 
deficit of cholinergic neurons; where transmission of 
information is suppressed due to lack of neurotransmitters 
such as acetylcholine (ACh) (Auld et al. 2002). Apart 
from that, the regulation of acetylcholinesterase (AChE) 
is also very important in maintaining the degradation of 
acetylcholine. Excessive amounts of acetylcholinesterase 
however, results in low levels of acetylcholine, resulting 
in memory impairment (Pepeu & Giovannini 2010). 
Deterioration of cholinergic deficiency can be alleviated 
by inhibiting acetylcholinesterase. Studies by previous 
investigators showed that natural products such as 
Emblica officinalis and Thesesia populnea have the 
ability to inhibit acetylcholinesterase activity (Vasudevan 
& Parle 2007; 2006). In fact, most of the AD drugs such 
as tacrine, donepezil, galantamine and rivastigmine are 
anticholinesterase inhibitors (Samadi et al. 2011; Zheng 
et al. 2010).
 Neurodegeneration via inflammatory pathway can 
also lead to memory loss. Proinflammatory cytokines 
and reactive oxygen species (ROS) produced by activated 
microglia cells and astrocytes may cause neuronal damage 
or neurotoxicity resulting in apoptosis and necrosis (Glass 
et al. 2010). Moreover, proinflammatory mediators released 
from microglial and astrocytes can activate each other 
to amplify inflammatory signals to neurons. The major 
proinflammatory cytokine which has been reported with 
elevation in AD is IL-1β (Pan et al. 2010). Other common 
anti-inflammatory cytokines include IL-4, IL-10, and TGF-β 
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(Akiyama et al. 2000). In neuroinflammation, the balance 
between pro- and anti- inflammatory mediators is very 
crucial. 
 Soybean (Glycine max L.) is a legume that is rich in 
indigenous isoflavones (Barnes 2010). Intake of soybean 
and its fermented products have been linked to many 
health benefits. Soybean has been shown to lower the 
incidence of cardiovascular diseases, risk of ischemic 
stroke and lower cholesterol levels reducing the incidence 
of atherosclerosis (Liang et al. 2009; Nagarajan et al. 
2008; Pyo & Seong 2009; Reynolds et al. 2006). Efficacy 
of soybean phytochemicals has also been studied for its 
anticancer properties in various cancer types. Soybean 
intake was reported to reduce the risk of breast, prostate 
and also endometrial cancers (Goodman et al. 1997; 
Hwang et al. 2009; Korde et al. 2009). Besides, soybean 
has always been associated with lowering menopausal 
symptoms in women and in reducing the chances of 
diabetic type 21 (Pipe et al. 2009; Villa et al. 2009). 
Nonetheless, soybean is also well recognized to possess 
antioxidant activity (Devi et al. 2009). In recent years, 
interest on the health benefits of soybean in the prevention 
and management of AD has increased. Using different 
maze models, rats supplemented with soybean were found 
to improve memory and act as an acetylcholinesterase 
inhibitor (Bagheri et al. 2011; Ding et al. 2011; Yang et 
al. 2011). 
 Tempeh is soybean cake that is fermented with 
Rhizopus oligosporus, which originated from Indonesia 
and is a commonly available in Malaysia. Tempeh has 
been studied mostly for its antioxidant properties (Chang 
et al. 2009). The relationship between antioxidant and 
neuroprotection have been documented, however the 
neuroprotective potential with specific mechanisms of 
tempeh is rather scarce. In our previous studies we found 
tempeh to reverse scopolamine-induced amnesia, improve 
cholinergic activities and reduce neuroinflammaton in rats 
(Ahmad et al. 2014). In a more recent study we indicated 
that tempeh exhibited β-sectretase activity in vitro 
through bioactive aglycones (Ahmad et al. 2015). The 
present study is therefore, aimed to evaluate and compare 
the memory enhancing effects and neuroprotective 
potential of soybean and tempeh extracts in normal rats. 
MATERIALS AND METHODS
SOYBEAN AND TEMPEH EXTRACT PREPARATION
Soybeans (1 kg) were soaked overnight in tap water and 
the beans were dehulled followed by soaking for another 
24 h. The dehulled soaked soybeans were boiled for 30 
min. The beans were then cooled and the surface dried 
and either directly frozen at -80°C (500 g as a control 
without fermentation) or fermented with Rhizophus sp. 
after mixing with the fungus, the beans were incubated in 
air tight plastics at 28°C for 3 days. The fermented soybean 
cake, tempeh was then cut into small pieces and frozen 
at -80°C. After two days, both soybean and tempeh were 
lyophilised. The sample was coarsely grinded before being 
stored in air tight condition.
 The extraction method was based on a previous 
standard protocol (Wei et al. 2004) but with slight 
modifications (Ahmad et al. 2015, 2014). 500 g of freeze-
dried soybean and tempeh were weighed into separate 
conical flasks. 5 L of 80% methanol was added into the 
flasks. The flasks were shaken at 60°C for an hour. The 
solutions were centrifuged at 3800 g for 10 min. The 
upper layer of the solution was collected and evaporated 
to dryness. The dried material was dissolved in 2.5 L of 
50% methanol and extracted 3 times with 2.5 L n-hexane. 
The methanol phase was concentrated and freeze-dried for 
storage. The collected extracts were standardized by the 
presence of major glycosides (daidzin and genistin) and 
aglycones (daidzein and genistein) using HPLC analysis 
(Ahmad et al. 2015). 
VEHICLES USED FOR DRUG AND SOYBEAN 
OR TEMPEH EXTRACTS
Piracetam (400 mg/kg) was diluted in normal saline. The 
freeze-dried soybean and tempeh extracts were suspended 
separately in 0.5% (w/v) carboxy methyl cellulose sodium 
(CMC) to concentrations of 10, 20 and 40 mg/kg. The 
extracts and piracetam were administered orally. 
EXPERIMENTAL DETAILS
All the experiments were carried out using male, Sprague-
Dawley rats, which were purchased from the animal house 
at Institute of Medical Research, Kuala Lumpur, Malaysia. 
Young (3-4 months) rats weighing about 180 ± 20 g were 
used in the present study. The animals were kept at the 
Laboratory and Facility of Animal Management (LAFAM), 
Faculty of Pharmacy, UiTM Puncak Alam, Selangor, 
Malaysia, of which the temperature and light were controlled 
at 26°C and a 12 h light cycle starting from 0700 to 1900. 
The animals had free access to standard laboratory food 
and water ad libitum. The Research Committee on the 
Ethical Use in Research (UiTM Care) Universiti Teknologi 
MARA, Malaysia, approved the experimental protocol 
(600-FF(PT.5/2)) and the care of laboratory animals was 
taken as per the guidelines of the Guide for the Care and Use 
of Laboratory Animals (National Research Council 2011).
ACUTE TOXICITY STUDIES
Acute toxicity studies were performed according to the 
Organization for economic co-operation and development 
(OECD423) guidelines (Ecobichon 1997). The animals were 
employed by random sampling technique. The animals 
were fasted for 4 h with access to water only. Soybean and 
tempeh extracts were administered orally at a dose of 5 mg/
kg initially and any signs of mortality were observed for 3 
days. If mortality was observed in two out of three animals, 
then the dose administered was considered as toxic dose. 
However, if the mortality was observed in only one out 
of three animals then the same dose was repeated again 
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to confirm the toxic effect. If no mortality was observed, 
only higher (50, 300 & 2000 mg/kg) doses of soybean and 
tempeh extracts were employed for further toxicity studies. 
DRUG ADMINISTRATION
The rats were divided into 16 groups (6 animals per group). 
Control group was administered with normal saline while 
piracetam (400 mg/kg) acted as the reference drug group. 
Soybean (S10, S20 and S40) and tempeh (T10, T20 and 
T40) extract groups were administered orally at three 
concentrations (10, 20 and 40 mg/kg). Different sets of 
animals were used for radial arm maze (RAM) and elevated 
plus-maze (EPM) tasks. 
RADIAL ARM MAZE
The radial arm maze was designed to measure spatial and 
learning memory of rats. It consists of eight arms made 
from black Plexiglas, numbered from 1 to 8 (48 × 12 cm), 
extending radially from a central area (32 cm in diameter), 
50 cm above the floor and was surrounded by an extra maze 
(outside) visual cues placed on the same location during the 
study. The timeline during treatment is illustrated in Figure 
1. Initially, the rats were acclimatized for 5 days to the 
laboratory environment. Since RAM is a food motivational 
task, prior to training, all rats were put on a restriction diet 
for 7 days (from 6th day) to maintain their weight at 85% 
of their free-feeding period (Foyet et al. 2011). On average, 
only 12 g of food pellet was given to each animal within 
the diet restriction period with water ad libitum. Every day, 
food was only given from 0900 to 1100 h and the animals 
were weighed. The treatment started after 7 days (from 
13th day) of diet restriction. On the 15th day, each animal 
was exposed to 5 min training for 5 consecutive days (15 to 
19th day) before the actual assessment began. The training 
was to adapt animals to the maze so they can explore, learn 
and consume food freely. The shaping of food location 
was important for the evaluation of animal learning and 
memory. On the first day, food was scattered all over the 
maze (Boast et al. 2000). On the second day, food was only 
available in all arms of the maze. On the third day, the food 
was available with the baited arms (1, 2, 4, 5 & 7) at the 
entrance of the arm. For the fourth and fifth day, food was 
only available at half way of the arm and finally at the end 
of the arm, in the cup, respectively. Along with training, 
the animals were given oral administration of extracts 
(S or T), control and standard drug. After 90 min of oral 
administration each animal was placed individually in the 
center of the maze. For memory assessment, the parameters 
were assessed for eight consecutive days from the 20th day 
of the experiment. Criterion performance was taken and 
it was defined as consumption of all 5 baits or until 5 min 
had elapsed. An arm entry was counted when all four limbs 
of the rat were within an arm. The parameters taken were 
working memory error (entering an arm containing food, 
but previously entered), reference memory error (entering 
an arm that was not baited) and time taken to consume all 
5 baits (Foyet et al. 2011). 
ELEVATED PLUS MAZE
The elevated plus maze for rat consists of two open (50 × 
10 cm) and two enclosed (50 × 40 × 10 cm) arms. With the 
arms extended from the central platform (10 × 10 cm) and 
the maze is elevated 50 cm from the floor. The procedure 
used was as described by previous study (Mani et al. 2012). 
On the first day (14th day of treatment), each rat was 
placed at the end of the open arm, away from the central 
platform after an hour of oral administration according to 
the groups. Time taken for the rat to move from the open 
arm to either one closed arm was monitored. The duration 
is known as transfer latency (TL), with 90 s maximum time 
allowed for each animal in each trial. If the animal did not 
move within 90 s, the animal was gently pushed into the 
closed arm. The animal was allowed to explore the maze 
for another 2 min before returning to the cage. Retention 
of this learned-task memory was measured after 24 h of 
the first day trial (15th day, 24 h after the first dose). The 
reduction in TL of the retention indicated improvement in 
memory. The timeline for this task is illustrated in Figure 2. 
COLLECTION OF BRAIN SAMPLES
At the end of the elevated plus maze experiment, animals 
were sacrificed by cervical decapitation under light 
FIGURE 1. Experimental scheme for radial arm maze task
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anaesthesia. Immediately after decapitation, the whole 
brain was carefully removed from the skull. For preparation 
of brain homogenate, the fresh whole brain was weighed 
and transferred into a glass homogenizer and homogenized 
using an ice bath after adding 10 volumes of normal saline 
solution. The homogenate was centrifuged at 3000 rpm for 
10 min and the resultant cloudy supernatant liquid was used 
for estimation of brain acetylcholine, acetylcholinesterase 
and cytokines measurements.
ACETYLCHOLINE ASSAY
The brain acetylcholine level was measured in a 96 well 
plate reader, following the procedure of EnzyChrom 
assay kit (USA). The method was based on the hydrolysis 
of acetylcholine by acetylcholinesterase to choline, 
which is oxidized by choline oxidase to betaine and 
H2O2. The resulting H2O2 reacts with a specific dye to 
form a pink colored product. The colour intensity at 570 
nm or fluorescence intensity (530/585 nm) is directly 
proportionate to the acetylcholine concentration in the 
sample (Vizi et al. 1985). 
ACETYLCHOLINESTERASE ASSAY
The assay of acetylcholinesterase was based on an 
improved Ellman method on a 96 well plate reader using 
a QuantiChrome assay kit (USA) (Kovarik et al. 2003). The 
procedure is based on production of thiocholine by the 
action of acetylcholinesterase, which forms yellow color 
with 5,5’-dithiobis(2-nitrobenzoic acid). The intensity 
of the product colour, was measured at 412 nm and is 
proportionate to the enzyme activity in the sample. 
INTERLEUKIN-1β (IL-1β) AND INTERLEUKIN-10 
(IL-10) MEASUREMENT
The higher doses of both extracts (S40 and T40) were 
selected for cytokine measurements. It was performed by 
using Procarta® Immunoassay kit – Polystyrene beads from 
Affymetrix that combined with quantitative, multiplexed 
immunoassays based on the Luminex® technology. The 
kit was specifically designed with two interest cytokines, 
which were IL-1β and IL-10. Multiple-analyte profiling 
beads were used for the detection and quantification of the 
interest target protein in brain tissue simultaneously. The 
concentration of protein in the sample was calculated by 
plotting the expected concentration of the standards against 
the Multiplex Fluorescent Immunoassay (MFI) generated 
by each standard. 
STATISTICAL ANALYSIS
All the results were expressed as mean ± Standard Error 
(SEM). Data was analyzed using one-way ANOVA followed 
by Dunnett’s t-test test. The results were considered as 
statistically significant at p<0.05.
RESULTS
ACUTE TOXICITY STUDY
Since there was no sign of mortality when the animals 
were orally treated with 300 mg/kg of soybean and tempeh 
extracts, three doses were selected (10, 20 and 40 mg/kg) 
to be used in this experiment. 
RADIAL ARM MAZE
Using radial arm maze, three parameters were observed; 
time taken to consume all baits, working memory errors 
and reference memory errors. These parameters represent 
the learning ability and memory capacity of the test 
animals.
 On the first day of the memory assessment, only T40 
showed a significant reduction (p<0.05) as compared 
to control, while other groups (S10, S20, S40, T10 & 
T20) including the standard drug showed no significant 
reduction in the time to finish all baits (Figure 3). 
However, a pattern of time reduction was observed in 
all groups within eight days of assessment. This same 
pattern was observed in the saline treated control group. 
For the piracetam group, significant reductions (p<0.05) 
were observed from day 3 onwards when compared to 
control. In soybean treated groups, only the S40 group 
showed significant (p<0.05) reduction on days 3, 4, 5 
and 8 when compared to control group. These results 
indicated that higher concentrations of soybean extract 
(S40) exerted a better effect in memory improvement than 
lower concentrations (S10 and S20). The same pattern 
was also observed in the tempeh extracted groups. The 
FIGURE 2. Experimental scheme for elevated plus maze
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high concentration of extract T40 exerted lesser time 
(p<0.05) to consume all baits from day 1 to day 8 when 
compared to control. The lower concentration of tempeh 
extract T20 only showed significant reductions (p<0.05) 
in the time taken to consume all five baits on days 7 and 
8. The results also indicate that there was no significant 
difference between T40, S40 and piracetam after the third 
day onwards. 
 Short term memory enhancing effect was measured 
by a reduction of the number of working memory errors 
(WME). In piracetam group, reductions (p<0.01) in WME 
were observed from day 3 onwards (Figure 4). For the 
soybean extract group, no significant difference was 
observed in the lowest S10 treated group. In S20 group, 
significant reductions (p<0.05) when compared with the 
control were observed only towards the end, on days 7 and 
8. The S40 group showed a significant reduction (p<0.05) 
at all days with no error observed at the final day when 
compared to control. In tempeh treated group, T10 showed 
a significant reduction (p<0.05) when compared to control 
group throughout the test period with no errors on the 
final day. The T20 group when compared to the control, 
exhibited significant reductions (p<0.05) throughout the 
experimental days except day 2. There were no significant 
differences in the WME among the soybean treated groups 
(S10, S20 and S40) except on day 8 where S20 and S40 
showed significantly (p<0.05) lesser errors than S10. There 
were no significant differences between the tempeh treated 
groups on WME. Only T20 and T40 exhibited significantly 
(p<0.05) lesser errors than the S10 group, whilst T20 
and T40 groups, were significantly better (p<0.05) than 
piracetam and the S40 groups in the first few days of the 
assessment. 
 Significant decrease in reference memory error 
(RME) indicates improvement in memory. In Figure 5, the 
control group showed the same RME pattern throughout 
the experimental period. The piracetam group showed 
significant (p<0.05) reductions in RME on days 6 to 8 
when compared to the control. In the soybean treated 
group, no significant reductions were observed in S10 and 
S20 throughout the experiment but S40 group was better 
(p<0.01) than control on the final day. In the tempeh treated 
group, no significant (p<0.01) reduction was observed until 
day 8 in groups T10 and T20 and days 7 and 8 in group T40 
when compared to control. The S40 group was significantly 
(p<0.05) improved when compared to S10 only on days 
7 and 8, otherwise there was no significant differences 
among the soybean treated groups. Similar results were 
found among the tempeh treated groups only T40 was 
significantly (p<0.05) better on day 6 when compared to 
T10. The T40 group reduced the RME significantly (p<0.05) 
when compared with S10 and S20 at days 7 and 8. However 
there were no significant differences between tempeh and 
piracetam even at the highest dose, T40. 
a significantly difference (p<0.05) as compared with control of respective day
b significantly difference (p<0.05) as compared with piracetam of respective day
c significantly difference (p<0.05) as compared with S10 of respective day
d significantly difference (p<0.05) as compared with S20 of respective day
e significantly difference (p<0.05) as compared with S40 of respective day
f significantly difference (p<0.05) as compared with T10 of respective day
g significantly difference (p<0.05) as compared with T20 of respective day
FIGURE 3. Effect of soybean (10, 20 and 40 mg/kg) and tempeh (10, 20 and 40 mg/kg) extracts administered orally 
for 15 days on time taken to consume all five baits during eight days of memory assessment in radial arm maze 
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FIGURE 4. Effect of soybean (10, 20 and 40 mg/kg) and tempeh (10, 20 and 40 mg/kg) extracts administered orally for 
15 days on the number of working memory errors during eight days of memory assessment in radial arm maze task
a significantly difference (p<0.05) as compared with control of respective day
b significantly difference (p<0.05) as compared with piracetam of respective day
c significantly difference (p<0.05) as compared with S10 of respective day
d significantly difference (p<0.05) as compared with S20 of respective day
e significantly difference (p<0.05) as compared with S40 of respective day
FIGURE 5. Effect of soybean (10, 20 and 40 mg/kg) and tempeh (10, 20 and 40 mg/kg) extracts administered orally for 
15 days on the number of reference memory errors during eight days of memory assessment in radial arm maze task
a significantly difference (p<0.05) as compared with control of respective day
b significantly difference (p<0.05) as compared with piracetam of respective day
c significantly difference (p<0.05) as compared with S10 of respective day
d significantly difference (p<0.05) as compared with S20 of respective day
e significantly difference (p<0.05) as compared with S40 of respective day
f significantly difference (p<0.05) as compared with T10 of respective day
ELEVATED PLUS MAZE
A significant reduction in TL values (on 16th day) indicated 
improvement in memory (Boast et al. 2000) as shown in 
Figure 6. All the treatments including piracetam showed 
significant (p<0.05) reduction of TL as compared to the 
control group except T10. In fact T10 showed significantly 
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(p<0.05) poorer memory when compared to all the other 
treatments. No significant differences were found among 
the soybean treated groups S10, S20 or S40. There was also 
no significant differences between piracetam, T40 and S40. 
ACETYLCHOLINE LEVEL
The level of brain acetylcholine is shown in Figure 7. 
Piracetam (48.2 μM) the reference drug showed significant 
a significantly difference (p<0.05) as compared with control 
b significantly difference (p<0.05) as compared with piracetam 
c significantly difference (p<0.05) as compared with S10 
d significantly difference (p<0.05) as compared with S20 
e significantly difference (p<0.05) as compared with S40
FIGURE 7. Effect of soybean (10, 20 and 40 mg/kg) and tempeh (10, 20 and 40 mg/kg) extracts 
administered orally for 15 days on the level of brain acetylcholine levels
(p<0.05) increase of acetylcholine level when compared 
to control (18.88 μM). Tempeh extract treated groups 
also showed significant improvements (p<0.05) with 
concentrations at 42.0, 51.5 and 57.8 μM for doses of T10, 
T20 and T40, respectively. The soybean extract treated 
groups did not show any significant differences with the 
control group. Based on the results achieved, tempeh 
extract showed similar acetylcholine levels as compared 
to piracetam.
FIGURE 6. Effect of soybean (10, 20 and 40 mg/kg) and tempeh (10, 20 and 40 mg/kg) extracts 
administered orally for 15 days on the transfer latency in elevated plus maze task
a significantly difference (p<0.05) as compared with control 
b significantly difference (p<0.05) as compared with piracetam 
c significantly difference (p<0.05) as compared with S10 
d significantly difference (p<0.05) as compared with S20 
e significantly difference (p<0.05) as compared with S40 
f significantly difference (p<0.05) as compared with T10
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ACETYLCHOLINESTERASE ACTIVITY
The effect of soybean and tempeh extracts on the 
acetylcholinesterase activity is shown in Figure 8. The 
reference drug, piracetam (51.2 U/L) showed a reduction 
(p<0.05) in acetylcholinesterase activity as compared 
to control (122.8 U/L). Significant reductions (p<0.05) 
were also noticed in tempeh extract treated groups at 
concentrations of T20 (76.61 U/L) and T40 (57.61 U/L). 
Soybean extracts (S10, S20 and S40) however did not 
show any significant differences with the control and the 
acethylcholinesterase activity was much higher (p<0.05) 
than piracetam. In general T20 and T40 groups reduced 
acethycholinesterase similar to that of piracetam.
IL-1β AND IL-10 MEASUREMENT
The effect of soybean and tempeh extracts (40 mg/kg) 
on the IL-1β level within the brain is shown in Figure 9. 
The results showed that piracetam (1.3 pg/mL) decreased 
the level of IL-1β significantly (p<0.05) as compared to 
control (3.9 pg/mL). The levels of IL-1β were reduced 
significantly (p<0.05) in S40 (2.25 pg/mL) and T40 
(0.38 pg/mL) groups as compared to control. The results 
showed that T40 was able to reduce the IL-1β better than 
S40 and piracetam. 
 IL-10 within the brain homogenate of the piracetam 
and the tempeh T40 groups were significantly (p<0.05) 
increased up to 14.15 pg/mL and 11.12 pg/mL respectively 
as compared to control group (6.24 pg/mL) (Figure 10). 
No significant changes were observed in the S40 group. 
DISCUSSION
Learning is an adaptive behavior influenced by experience 
while memory is the neuronal activity of experience storage 
(Kovarik et al. 2003). Animal and human survive through 
the ability of learning and memory, which take part in 
the brain. Working memory is involved in temporarily 
maintaining cues of previously experienced events or 
it can be called short term memory. Reference memory 
means the performance based on well-learned responses 
in the presence of current stimulus or unmoved cues along 
the study. Reference memory can also be referred to as 
long term memory. Memory loss is one of the important 
features that advance with aging. However, memory loss 
is more common in neurodegenerative disease or due to 
injury to the brain. In the present study, we examined 
the effect of extracts from soybean and the fermented 
product tempeh on memory using radial arm maze and 
elevated plus maze. The results of these behavioral studies 
indicated that both the extracts have the ability to improve 
the cognitive performance in both the models. Both the 
extracts facilitated cholinergic activities and ameliorated 
the neuronal inflammation processes. 
 Radial arm maze (RAM) was used to evaluate the 
effects of soybean and tempeh extracts on the spatial 
learning and memory of the animals. In RAM, three 
parameters were chosen; the time taken to consume all 
baits, reference memory error (RME) and working memory 
error (WME). Reference memory and working memory are 
the two variables that report the physiological status of the 
a significantly difference (p<0.05) as compared with control 
b significantly difference (p<0.05) as compared with piracetam 
c significantly difference (p<0.05) as compared with S10 
d significantly difference (p<0.05) as compared with S20 
e significantly difference (p<0.05) as compared with S40 
f significantly difference (p<0.05) as compared with T10 
FIGURE 8. Effect of soybean (10, 20 and 40 mg/kg) and tempeh (10, 20 and 40 mg/kg) extracts 
administered orally for 15 days on the activity of brain acetylcholinesterase activities
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FIGURE 9. Effect of soybean (40 mg/kg) and tempeh (40 mg/kg) extracts administered orally for 15 
days on brain IL-1β levels. Values are in mean ± SEM (n=6)
a significantly difference (p<0.05) as compared with control 
b significantly difference (p<0.05) as compared with piracetam
c significantly difference (p<0.05) as compared with S40
FIGURE 10. Effect of soybean (40 mg/kg) and tempeh (40 mg/kg) extracts administered 
orally for 15 days on brain IL-10 levels. Values are in mean ± SEM (n=6) 
a significantly difference (p<0.05) as compared with control 
b significantly difference (p<0.05) as compared with piracetam
c significantly difference (p<0.05) as compared with S40
brain (Titus et al. 2007). The results showed that the time 
taken for the animal to consume all baits reduced during 
the eight days of assessment among the various groups. 
The reduction in time suggests the ability of the rats to 
recognize the maze and external cues based on experience. 
Short term memory improvement exerted by the soybean 
and tempeh extracts was represented by the significant 
reduction of WME in animal models. The improvement 
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of long term memory was represented by significant 
reduction in RME. The results obtained in the present 
study showed that in general tempeh extract improved 
memory better than soybean extract in the first few days 
of the assessment. Our previous results indicated that 
the amount of the most bioavailable aglycones such as 
daidzein and genistein was more abundant in the tempeh 
extract as compared to soybean extract (Ahmad et al. 
2015). The higher aglycones in the tempeh extract may 
possibly enhance memory better than soybean extract. 
Reduction of transfer latency (TL) observed also indicates 
an improvement of memory in both soybean and tempeh 
extracts in the treated groups. 
 Cholinergic neurons of the brain play a vital role in the 
cognitive deficits related to aging and neurodegenerative 
diseases. In the brain of senile dementia of the Alzheimer’s 
type, the common features observed included selective loss 
of cholinergic neurons, decrease in acetylcholine level and 
an increase of acetylcholinesterase activity (Auld et al. 
2002). According to the cholinergic hypothesis, memory 
impairments in patients with senile dementia are due to a 
selective and irreversible deficiency of the brain cholinergic 
functions (Overk et al. 2010). Acetylcholinesterase 
involves the regulation of acetylcholine to proper levels. 
However, excessive acetylcholinesterase activity leads 
to constant acetylcholine deficiency and cognitive 
impairments (Pepeu & Giovannini 2010). According to 
the study, soybean isoflavones can influence the brain 
cholinergic system and cognitive function, by increasing 
the level of acetylcholine through the inhibition of 
acetylcholinesterase (Yang et al. 2011). In the present study, 
the tempeh extract down-regulated acetylcholinesterase 
activity and up-regulated the acetylcholine level even 
better than the soybean extract. The reduction of the brain 
acetylcholinesterase activities observed using both tempeh 
and soybean extracts may facilitate the improvement of 
memory in treated animals. Since the cholinergic system 
plays a vital role in the process of learning and memory, 
the inhibition of acetylcholinesterase is often targeted as 
therapeutics in AD.
 Interleukin-1 (IL-1) is a pluripotent immunomodulatory 
cytokine that has an initiating role in cellular and humoral 
immunity in the periphery. IL-1α and IL-1β are partially 
homologous isoforms of IL-1 and both have a quite 
similar tertiary structure. The physiological function of 
interleukin-1 beta (IL-1β) has been known to initiate the 
immune response by playing a vital role in the trigger 
and the development of a complex hormonal and cellular 
inflammatory cascade (Rubio-Perez & Morillas-Ruiz 
2012). It is detected in brain within a few hours after 
brain injury (Winter et al. 2002). Moreover, it was also 
believed that IL-1β would promote the progression 
of neurodegeneration. Nonetheless, previous study 
suggested that the IL-1β was high in the brain of AD 
transgenic mice (Patel et al. 2005). The IL-1β also relates 
to the pathology of AD through inducible NO production 
and a decline in the cholinergic functions through the 
increase of acetylcholinesterase levels, which in turn 
leads to the progressive neurodegeneration. The results 
from this study showed that the reduction of IL-1β levels 
by both extracts also correlated to the lower levels of 
acetylcholinesterase activities in this study. The reduction 
of IL-1β levels further suggests that these extracts have 
anti-inflammatory properties within the brain. The 
results were consistent with that obtained by a previous 
investigator (Danciu et al. 2012), of which soy isoflavones 
exhibited the ability to act as an anti-inflammatory agent. 
The present study shows that fermented soybean tempeh 
showed better results as a functional food as compared 
to soybean. 
 The IL-1β is a promoter to inflammatory activity, 
however, IL-10 is said to be a potent anti-inflammatory 
cytokine. This anti-inflammatory mediator is able 
to suppress the production of IL-1β, TNF and other 
chemokines that are pro-inflammatory mediators. In AD, 
it is hypothesised that Aβ plaques and tangles trigger a 
chronic inflammatory reaction to clear this debris (Town 
et al. 2005). Therefore, IL-10 might be crucial in dealing 
with brain injury due to inflammation. A clinical study 
found that various IL-10 polymorphisms may lower the 
risk of AD (Lio et al. 2003). In the present study, the level 
of IL-10 in the tempeh extract treated group improved, 
but no significant improvements were observed in the 
groups treated with soybean extract at the same dose 
levels. Improvement of soybean aglycones during the 
fermentation process might (Ahmad et al. 2015) play a 
crucial role in the elevation of anti-inflammatory cytokine 
IL-10 levels in the tempeh extract treated groups.
CONCLUSION
In the present study, using a radial arm maze and elevated 
plus maze we observed that both soybean and tempeh 
extracts, improved memory. Both extracts facilitated the 
central cholinergic activity by elevating the acetylcholine 
levels and inhibiting the cholinesterase enzyme activity in 
the brain. The levels of proinflammatory cytokine IL-1β 
was attenuated by both extracts but with tempeh being 
significantly better than the soybean extract. In fact, 
the anti-inflammatory cytokine IL-10 was elevated by 
tempeh extract only. The overall results highlighted that 
the tempeh extract exhibited better effects in most of the 
tested parameters as compared to soybean extract at the 
same dose levels and might be useful in the management 
as well as prevention of dementia and Alzheimer’s 
disease. 
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